Mir A Imran Net Worth & Insider Trades

Mir A Imran - Director, Rani Therapeutics Holdings, Inc

As of August 25, 2022

What is Mir A Imran's Net Worth?

The current estimated net worth of Rani Therapeutics Holdings, Inc's Director, Mir A Imran, is estimated to be about $988.41K . Mir A Imran owns about 66,445 units of Rani Therapeutics Holdings, Inc common stock. In the last 6 months at Rani Therapeutics Holdings, Inc, Mir A Imran has sold an estimated value of $853.67K worth.

What is Mir A Imran's Past Insider Trading?

Mir A Imran's largest sale order was 80,252 units , worth over $853.67K on August 19, 2022. In total, Mir A Imran has made about 3 transactions over 6 months of their time at Rani Therapeutics Holdings, Inc. Mir A Imran usually trades in August, with the busiest year in 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Rani Therapeutics Holdings, Inc's Past Insider Trades?

Rani Therapeutics Holdings, Inc's most recent insider trade came on November 21, 2023 by Jean-Luc Butel who bought 50,500 units worth $102.49K . In the last 2 years, insiders at Rani Therapeutics Holdings, Inc have sold an estimated value of $2.2M and bought an estimated value of $73.83M worth of shares. Insider trading is most common in March, with the busiest year in 2023. The most active traders at the company are South Cone Investments Limited Partnership,  South Lake One Llc,  and Andrew Farquharson, Director .

Rani Therapeutics Holdings, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...